Patient Engagement Solutions Market Trends, Company Share, Industry Growth And Future Scope: Grand View Research Inc.

 Patient Engagement Solutions Market Growth & Trends

The global patient engagement solutions market size is expected to reach USD 70.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 21.4% from 2021 to 2028. The market is expected to register exponential growth due to the adoption of m-health; increasing prevalence of chronic conditions such as diabetes, asthma, and arthritis; improved healthcare services; enhanced patient education; patient data tracking; and diagnostic treatment.

In January 2021, the Biden-Harris administration opened a “Special Enrollment Period”. Under this action, Americans to sign up for health coverage and roll back attacks on the Medicaid, Affordable Care Act, and access to reproductive health care. Hence, such orders meet the healthcare requirements formed by the COVID-19 outbreak, it will protect access to reproductive health care, and make health care system easier and more unbiassed. Such initiatives are anticipated to drive the demand for these services over the forecast period.

As healthcare providers were battling with the constant upsurge in numerous cases, patients were looking to digital technologies for the support which promoted the adoption of a product. The outbreak has resulted in the introduction of multiple COVID-19- related features patient engagement solutions by various players. The growing number of smartphone users around the globe expedited the adoption of mHealth across the sector both from providers and consumers which in turn, has augmented the dependability of patients on mHealth apps.

Moreover, in March 2019, the American Medical Association entered a collaboration with Patient Point with the aim to access point of care to help prevent the occurrence of cardiovascular diseases and type 2 diabetes. Using Patient Point technology, approximately 6,500 practicing doctors across U.S. are expected to educate individuals regarding disease prevention. Programs such as these are expected to drive market growth over the forecast period.

The necessity of social distancing resulted in the demand for remote patient monitoring solutions along with the prerequisite for the precise and timely exchange of patient wellbeing records. The pandemic has also made healthcare professionals look for alternate methods to traditional processes and systems. As a result, market participants had come up with COVID-19- related features into their existing patient engagement solutions. For instance, in 2020, Orion Health has established the first complete pandemic outbreak monitoring platform to control the spread of the coronavirus. Hence, it led to the adoption of the solutions.

Request a free sample copy or view report summary: Patient Engagement Solutions Market Report

Patient Engagement Solutions Market Report Highlights

• The web-based/cloud-based emerged as the largest delivery type segment in 2020 and accounted for over 80.0% revenue share as it supports hassle-free information flow between patients and healthcare providers. Moreover, bulk data can be stored in these platforms and enable remote access
• The software segment dominated the market in 2020, owing to continuous development in patient engagement solutions along with its increasing applications in consulting, education, and implementation. Software solutions are easy to install and use, enable quick access to specific drug information, and enable healthcare providers to digitally upload prescriptions
• Rising prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes, which require constant monitoring, is expected to drive the demand for these services in the coming years
• The chronic diseases segment dominated the market in 2020 owing to the associated benefits of these solutions in chronic disease management. These solutions help patients connect with their healthcare providers from remote locations, thereby enabling streamlined flow of information, patient feedback, and other health-related data
• North America dominated the market in 2020 owing to increased adoption of m-health and Electronic Health Record (EHR) and growing investments in patient engagement software by major companies
• Companies are adopting various strategies to sustain competition. New product/solution development, partnerships, mergers, acquisitions, strategic collaborations, and geographical penetration are some of the key strategies adopted by market players  

Access Press Release of Patient Engagement Solutions Market@ https://www.grandviewresearch.com/press-release/global-patient-engagement-solutions-market

Patient Engagement Solutions Market Segmentation

Grand View Research has segmented the global patient engagement solutions market based on delivery type, component, end-use, application, therapeutic area, and region:

Patient Engagement Solutions Delivery Type Outlook (Revenue, USD Million, 2016 - 2028)

• Web-based/Cloud-based
• On-premise

Patient Engagement Solutions Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software
  • Standalone
  • Integrated
• Services
  • Consulting
  • Implementation
  • Education
  • Others
• Hardware

Patient Engagement Solutions End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Payers
• Providers
• Individual Users

Patient Engagement Solutions Application Outlook (Revenue, USD Million, 2016 - 2028)

• Social Management
• Health Management
• Home Healthcare Management
• Financial Health Management

Patient Engagement Solutions Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

• Chronic diseases
  • Obesity
  • Diabetes
  • Cardiovascular
  • Others
• Fitness
• Women's Health
• Mental Health
• Others

Patient Engagement Solutions Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Patient Engagement Solutions Market

• Allscripts Healthcare Solutions
• McKesson Corporation
• Orion Health Ltd.
• Cerner Corporation
• Phytel Inc.
• Medecision Inc.
• GetWellNetwork Inc.
• YourCareUniverse Inc.
• Lincor Solutions Ltd.
• Athenahealth, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Extracorporeal Membrane Oxygenation Machine Market Plying for Significant Growth During 2021-2028

 Extracorporeal Membrane Oxygenation Machine Market Growth & Trends

The global extracorporeal membrane oxygenation machine market size is expected to reach USD 398.6 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.

According to the WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Furthermore, increasing awareness about ECMO procedures, coupled with various government initiatives, is further propelling the growth.

The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth. Applications of ECMO machine procedures have been increased over the years. ECMO machine was traditionally used in cases of circulatory or respiratory failure. Its applications have expanded to use as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure.

The ECMO machine use has been rising gradually worldwide owing to its benefits such as artificial lung for the patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities is adding growth to the market. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030 from USD 320 billion in 2011. Major players in the market are focusing on technological collaboration and product launches.

Request a free sample copy or view report summary: Extracorporeal Membrane Oxygenation Machine Market Report

Extracorporeal Membrane Oxygenation Machine Market Report Highlights

• North America accounted for the largest share in 2020 owing to favorable reimbursement policies, the presence of key players, and government initiatives
• By component, the oxygenator segment accounted for the largest share in 2020 owing to its high cost and usage
• In terms of modality, the veno-arterial segment accounted for the largest share in 2020 and is expected to grow at the fastest rate during the forecast period
• Based on patient type, the adult segment is expected to grow at a rapid pace during the forecast period owing to the rising incidence of cardiac and pulmonary diseases
• On the basis of application, the respiratory segment held the largest market share in 2020 and is expected to grow at the fastest rate over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-extracorporeal-membrane-oxygenation-ecmo-market

Extracorporeal Membrane Oxygenation Machine Market Segmentation

Grand View Research has segmented the global extracorporeal membrane oxygenation machine market on the basis of component, modality, patient type, application, and region:

ECMO Machine Component Outlook (Revenue, USD Million, 2016 - 2028)

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

ECMO Machine Modality Outlook (Revenue, USD Million, 2016 - 2028)

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

ECMO Machine Patient Type Outlook (Revenue, USD Million, 2016 - 2028)

• Neonates
• Pediatric
• Adult

ECMO Machine Application Outlook (Revenue, USD Million, 2016 - 2028)

• Respiratory
  • Neonates
  • Pediatric
  • Adult
• Cardiac
  • Neonates
  • Pediatric
  • Adult
• ECPR
  • Neonates
  • Pediatric
  • Adult

ECMO Machine Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Czech Republic
  • Russia
  • Poland
  • Turkey
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Vietnam
  • Philippines
  • Malaysia
  • Indonesia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Oman
  • Kuwait

List of Key Players of Extracorporeal Membrane Oxygenation Machine Market

• Medtronic plc
• Sorin Group
• Terumo Cardiovascular Systems Corporation
• MAQUET Holding B.V. & Co. KG
• Medos Medizintechnik AG
• Nipro Medical Corporation
• Microport Scientific Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Vital Signs Monitoring Devices Market Revenue Sales to Reach $15.6 Billion by 2028

 Vital Signs Monitoring Devices Market Growth & Trends

The global vital signs monitoring devices market size is expected to reach USD 15.6 billion by 2028, according to the new report of Grand View Research, Inc. It is expected to expand at a CAGR of 8.9% over the forecast period. The growing prevalence of lifestyle-associated chronic conditions and rising demand for advanced monitoring devices in developing countries, such as China, India, Thailand, and Brazil, are some of the major factors driving the market. The availability of monitoring systems at competitive prices and increasing disposable income are expected to fuel the market growth during the forecast period.

The introduction of advanced, integrated vital signs monitoring solutions and the growing trend of the usage of these devices in home healthcare settings as well as all-time wearable devices for chronic patients are some of the factors expected to drive the market during the forecast period.

Blood pressure monitors emerged as the largest product segment in the market in 2020 due to the increasing incidence of hypertension and rising demand for blood pressure monitors designed for personal use. The hospitals' end-use segment dominated the market in 2020 due to the factors such as a large patient pool, financing capability, and requirement of vital signs monitors in bulk.

The demand for vital signs monitoring devices escalated due to the outbreak of COVID as a daily measurement of the vital sign can serve as an early detection system for the infection. These devices can also provide facility-based surveillance for healthcare-associated infections, including infections in healthcare workers and patients, which is one of the vital components of COVID-19 infection prevention and control measures. The use of vital signs monitoring for in-home settings also saw a surge w.r.t maintaining patient and provider safety while also allowing real-time access to vital signs via Cloud Portals.

Request a free sample copy or view report summary: Vital Signs Monitoring Devices Market Report

Vital Signs Monitoring Devices Market Report Highlights

• By product, blood pressure monitors held the largest market share in 2020 and are expected to exhibit a lucrative CAGR from 2021 to 2028
• Based on end-use, the hospitals' segment dominated the market in 2020. The segment is expected to maintain its lead throughout the forecast period owing to the high preference for advanced devices
• North America dominated the market in 2020 owing to the availability of major market players and high adoption of advanced technology
• Various manufactures are focusing on new product launches, technological innovations, collaborations, and regional expansion as major strategic initiatives

Access Press Release@ https://www.grandviewresearch.com/press-release/global-vital-signs-monitoring-devices-market

Vital Signs Monitoring Devices Market Segmentation

Grand View Research has segmented the global vital signs monitoring devices market on the basis of product, end-use, and region:

Vital Signs Monitoring Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Blood Pressure Monitors
  • Mercury Blood Pressure Monitors
  • Aneroid Blood Pressure Monitors
  • Digital Blood Pressure Monitors
  • Ambulatory Blood Pressure Monitors
  • Blood Pressure Instrument Accessories
• Pulse Oximeters
  • Table-Top/Bedside Pulse Oximeters
  • Fingertip Pulse Oximeters
  • Hand-Held Pulse Oximeters
  • Wrist-Worn Pulse Oximeters
  • Pediatric Pulse Oximeters
  • Pulse Oximeter Accessories
• Temperature Monitoring Devices
  • Mercury Filled Thermometers
  • Digital Thermometers
  • Infrared Thermometers
  • Liquid Crystal Thermometer
  • Temperature Monitoring Device Accessories
• Other Vital Sign Monitors

Vital Signs Monitoring Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Physician’s Office
• Home Healthcare
• Ambulatory Centers
• Emergency Care Centers
• Other Healthcare Settings

Vital Signs Monitoring Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Vital Signs Monitoring Devices Market

• Koninklijke Philips N.V.
• Medtronic
• Nihon Kohden Corporation
• GE Healthcare
• Masimo
• Omron Healthcare
• Contec Medical Systems Co. Ltd.
• A&D Company Ltd.
• Nonin Medical Inc.
• SunTech Medical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antibiotics Market Value Expected to Increase at a CAGR of 4.5% by 2028

 

Antibiotics Market Growth & Trends 

The global antibiotics market size is expected to reach USD 57.99 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.5% from 2021 to 2028. High usage of antibiotics and inappropriate prescription behavior of antibiotic drugs worldwide are the major factors anticipated to drive the market. Moreover, rising awareness among patients and healthcare professionals and increasing involvement of regulatory bodies in the R&D activities of new therapies to treat infectious diseases are expected to propel the market growth over the forecast period.

An increasing number of public-private collaborations, wherein funding and innovative R&D approaches are provided by public agencies to firms developing antibiotics, is expected to boost the product pipeline. For instance, in December 2018, Eisai Co., Ltd., and Takeda Pharmaceutical Company Limited announced an agreement with GARDP for the development of novel antibacterial compounds.

Betterment in the approval process of antibiotic drugs is expected to boost the market growth over the forecast period. In February 2020, Merck received acceptance for a review of supplemental New Drug Application (sNDA) from the U.S. FDA for RECARBRIO (imipenem, cilastatin, and relebactam) intended for HABP/VABP. This submission is anticipated to reinforce the continued dedication of the company to R&D pertaining to antibiotic therapies that address unmet medical needs.

Government reforms such as the Generating Antibiotics Incentives Now Act in the U.S. are projected to propel market growth in the coming years. This is further expected to facilitate the development process of advanced drugs. According to the Pew Charitable Trusts, about 30% of the outpatient oral antibiotic drug prescriptions are unnecessary and most of these prescriptions are for disease conditions against which antibiotics are not significantly effective, such as non-bacterial infections and acute respiratory conditions.

The market is highly competitive and major market players have almost similar market share. Pharmaceutical players are adopting strategies, including mergers & acquisitions, collaborations, and strategic alliances, to gain a competitive advantage. The major pharmaceutical companies are collaborating for developing novel therapies to reduce the cost burden of the drug development process. In December 2019, Appili Therapeutics signed an agreement with Saptalis Pharmaceuticals for the reformulation of antibiotic metronidazole. According to the agreement, Saptalis will be responsible for manufacturing, marketing of ATI-1501 in the United States. Moreover, in October 2018, Paratek Pharmaceuticals, Inc. entered into a license agreement for the development and commercialization of Seysara (sarecyline) with Allergan.

A group of key pharmaceutical players has launched AMR Action Fund worth USD 1 billion in July 2020. This fund is expected to support the research of innovative and novel antibiotics and is formed in collaboration with the European Investment Bank, the Wellcome Trust, and the World Health Organization.

Due to the lack of commercial success for newly developed antimicrobial drugs, government and non-government bodies have adopted strategies to incentivize antibiotic drug R&D activities. For instance, the government in alliance with BARDA is supporting several companies to boost the R&D activities in new therapies for infectious diseases. BARDA has also been associated with pharmaceutical companies, such as GSK, Tetraphase, and Basilea Astra Zeneca. CARB-X is investing around USD 109 million to support the early-stage development of potential therapeutic candidates.

Request a free sample copy or view report summary: Antibiotics Market Report

Antibiotics Market Report Highlights

• By action mechanism, the cell wall synthesis inhibitors segment accounted for the largest share of 52.1% in 2020 and is anticipated to maintain its lead over the forecast period
• Based on drug class, the cephalosporin segment held the second-largest share in 2020. Pipeline candidates in cephalosporin drug class such as Fetroja (cefiderocol), cefilavancin, and ceftobiprole are anticipated to drive the segment in the forecast period
• The others' drug class segment is expected to grow at the fastest rate during the forecast period. The segment consists of various existing classes of antibiotics as well as some newly developed drugs, such as tetracycline, carbapenem, imidazole, peptides, lincosamides, and monoclonal antibodies
• Asia Pacific was the largest regional market in 2020 and is expected to witness the fastest growth in the coming years owing to the rising consumption of antibiotics and high disease prevalence
• North America emerged as the second-largest regional market in 2020 owing to government initiatives for the development of new therapies and better reimbursement scenario

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antibiotic-market

Antibiotics Market Segmentation

Grand View Research has segmented the global antibiotics market on the basis of action mechanism, drug class, and region:

Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2017 - 2028)

• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others

Antibiotics Drug Class Outlook (Revenue, USD Million, 2017 - 2028)

• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolide
• Carbapenem
• Aminoglycoside
• Sulfonamide
• 7-ACA
• Others

Antibiotics Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Antibiotics Market

• Merck & Co., Inc.
• Allergan plc (AbbVie)
• GlaxoSmithKline plc.
• Pfizer Inc.
• Melinta Therapeutics
• Basilea Pharmaceutica Ltd.
• Tetraphase Pharmaceuticals
• Paratek Pharmaceuticals, Inc.
• Nabriva Therapeutics plc
• Spero Therapeutics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Infectious Disease In-vitro Diagnostics Market Trends And Forecast 2021-2028: Grand View Research Inc.

 Infectious Disease In-vitro Diagnostics Market Growth & Trends

The global infectious disease in-vitro diagnostics market size is expected to reach USD 76.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.9% from 2021 to 2028. This growth is owing to factors such as the increasing prevalence of infectious diseases, the outbreak of COVID-19, growing market penetration of available treatments, and increasing consumer awareness.

Diagnostics for SARS-CoV-2 detection are being continuously launched for catering to markets that have specific regulatory requirements. For instance, in September 2019, Roche launched its CE Marked antibody diagnostic test Elecsys Anti-SARS-CoV-2 S. Thus, the launch of new diagnostics is expected to lead to an increase in demand owing to their usage in the characterization of the vaccine-induced immune response, thereby boosting vaccine development.

Technological advancements, such as the introduction of portable instruments like Cobas 4800 developed by Roche Diagnostics and GeneXpert by Cepheid are expected to drive market growth over the forecast period. Furthermore, increasing use of these systems to develop new tests that can detect infectious diseases is expected to fuel market growth.

An increase in the prevalence of MRSA infection, high consumer awareness, and the presence of high unmet patient needs are some of the factors expected to drive the market during the forecast period. Diagnosis of MRSA infection involves rapid culture methods and molecular techniques for assessment of MRSA colonization. The presence of a large number of diagnostic tests and the introduction of new products, such as LightCycler, TaqMan, RotorGene, and Stratagene, are expected to propel segment growth.

The launch of new products is becoming a key strategy adopted by players, as new SARS-CoV-2 diagnostics are being launched by major players such as BD, bioMérieux SA, and F. Hoffmann-La Roche Ltd. For instance, in March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test for the diagnosis of COVID-19, and BioMedomics launched a PoC COVID-19 test that can detect antibodies in blood within 15 minutes.

Request a free sample copy or view report summary: Infectious Disease In-vitro Diagnostics Market Report

Infectious Disease In-vitro Diagnostics Market Report Highlights

• The reagents segment dominated the overall market majorly driven by the high usage rate
• The molecular diagnostics technology segment accounted for the highest revenue share in 2020. This can be attributed to the usage of PCR test for Covid-19 diagnosis
• The central laboratories segment accounted for a revenue share of around 60.0% in 2020
• North America accounted for the largest revenue share in 2020, driven by a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure
• The market is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ivd-infectious-disease-market

Infectious Disease In-vitro Diagnostics Market Segmentation

Grand View Research has segmented the global infectious disease in-vitro diagnostics market based on product, technology, application, end-use, and region:

Infectious Diseases IVD Product Outlook (Revenue, USD Million, 2017 - 2028)

• Instruments
  • MRSA
  • Streptococcus
  • Clostridium Difficile
  • VRE
  • CRE
  • Respiratory Virus
  • Candida
  • TB and Drug-resistant TB
  • Gastro-intestinal Panel Testing
  • Chlamydia
  • Gonorrhea
  • HPV
  • HIV
  • Hepatitis C
  • Hepatitis B
  • Covid-19
  • Others
• Reagents
  • MRSA
  • Streptococcus
  • Clostridium Difficile
  • VRE
  • CRE
  • Respiratory Virus
  • Candida
  • TB and Drug-resistant TB
  • Gastro-intestinal Panel Testing
  • Chlamydia
  • Gonorrhea
  • HPV
  • HIV
  • Hepatitis C
  • Hepatitis B
  • Covid-19
  • Others
• Services
  • MRSA
  • Streptococcus
  • Clostridium Difficile
  • VRE
  • CRE
  • Respiratory Virus
  • Candida
  • TB and Drug-resistant TB
  • Gastro-intestinal Panel Testing
  • Chlamydia
  • Gonorrhea
  • HPV
  • HIV
  • Hepatitis C
  • Hepatitis B
  • Covid-19
  • Others

Infectious Diseases IVD Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Immunoassay
• Molecular Diagnostics
• Microbiology
• Others

Infectious Diseases IVD Application Outlook (Revenue, USD Million, 2017 - 2028)

• MRSA
• Streptococcus
• Clostridium Difficile
• VRE
• CRE
• Respiratory Virus
• Candida
• TB and Drug-resistant TB
• Gastro-intestinal Panel Testing
• Chlamydia
• Gonorrhea
• HPV
• HIV
• Hepatitis C
• Hepatitis B
• Covid-19
• Others

Infectious Diseases IVD End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Point of care
• Central Laboratories
• Others

Infectious Diseases IVD Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players of Infectious Disease In-vitro Diagnostics Market

• BD
• bioMérieux SA
• Abbott
• Quidel Corporation
• OraSure Technologies, Inc.
• Hologic, Inc. (Gen-Probe)
• Danaher
• QIAGEN
• Hoffmann-La Roche, Ltd.
• Siemens Healthineers AG
• Bio-Rad Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Billing Outsourcing Market Latest Innovations, Drivers and Industry Key Events by 2028: Grand View Research Inc.

 

Medical Billing Outsourcing Market Growth & Trends

The global medical billing outsourcing market size is projected to reach USD 25.3 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.3% from 2021 to 2028. A large amount of clinical code representation for diagnosis and treatment coupled with the presence of multiple payers renders medical billing an intricate part of any clinical practice, posing significant challenges. Currently, the healthcare system is witnessing a subsequent rise in the outsourcing of clinical billing services by hospitals and physicians due to obligatory implementation of complex ICD-11 coding systems, increasing healthcare costs, and a federal mandate to implement Electronic Medical Records (EMR) to maintain reimbursement levels.

The COVID-19 pandemic has negatively affected the market. Though, the healthcare industry was trailing in embracing innovative and digital technologies to improve healthcare. The COVID-19 scenario has put an enormous burden on healthcare providers/organizations to become accustomed to the change. The recovery from the financial impact of the coronavirus pandemic could take a long time. Thus, players operating in the market need to create new policies/strategies powered by telemedicine solutions and patient-centric collections to rise above the challenges of COVID-19.  

Furthermore, clinics/physician offices are gradually outsourcing their revenue management to cut unnecessary costs and prevent the burden of managing an administrative team to ensure effective handling of in-house billing functions. In addition, multispecialty healthcare groups are implementing consolidation requiring EHR integration and building large healthcare networks. This integration creates a need for revenue cycle management (RCM), which, in turn, demands additional expertise and trained personnel to manage the same. Thus, the consolidation of large healthcare practices is also expected to be one of the factors fueling the market growth.

Request a free sample copy or view report summary: Medical Billing Outsourcing Market Report

Medical Billing Outsourcing Market Report Highlights

• The outsourced segment accounted for the largest revenue share in 2020 and is expected to witness a high CAGR attributed to the rising preference of hospitals, physician office, and startups opting for outsourced medical billing services for hassle-free claim management at low cost
• The front-end services segment led the market in 2020. However, the middle-end services segment is expected to register the highest CAGR over the forecast period due to the growing demand for Revenue Cycle Management (RCM) services offering Electronic Health Records (EHR) software
• Hospitals, possessing higher claim volumes, accounted for the largest revenue share in the market in 2020 and is estimated to maintain the dominance even during the forecast years
• North America held the largest revenue share in 2020. It is projected to expand further as U.S. has witnessed a change in the healthcare system with the introduction of ICD-11 coding in 2019 and pressure from the government to incorporate the Electronic Medical Record (EMR) management system
• Medical billing and Revenue Cycle Management (RCM) companies such as Athenahealth, are offering successful implementation of EMR at the practice level and are expected to transform the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-billing-outsourcing-market

Medical Billing Outsourcing Market Segmentation

Grand View Research has segmented the global medical billing outsourcing market on the basis of component, service, end-use, and region:

Medical Billing Outsourcing Component Outlook (Revenue, USD Million, 2016 - 2028)

• In-house
• Outsourced

Medical Billing Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

• Front-end
• Middle-end
• Back-end

Medical Billing Outsourcing End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
• Physician Office
• Others

Medical Billing Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Medical Billing Outsourcing Market

• R1 RCM, Inc.
• Allscripts; Cerner Corporation
• eClinicalWorks LLC
• Experian Information Solutions, Inc.
• GE Healthcare
• Genpact
• Kareo, Inc.
• McKesson Corporation
• Quest Diagnostics
• Cerner Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Urinary Catheters Market Precise Analysis on Business Overview, Product Scope And Ongoing Market Development

 Urinary Catheters Market Growth & Trends

The global urinary catheters market size is anticipated to reach USD 7.94 billion by 2028 registering a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from Urinary Tract Infections (UTI) and blockages in the urethra are anticipated to boost the product demand. The advent of technologically advanced products is also expected to drive market growth. For instance, RIOCATH - a Reversal Inside Out Catheterization, developed by Riocath global in collaboration with IOCB Prague, reduces the chances of infections in the body.

The key application segments include Benign Prostate Hyperplasia (BPH) & prostate surgeries, Urinary Incontinence (UI), spinal cord injury, and others. Among these, UI is the largest application segment owing to the increasing prevalence of the disease. Factors such as surgery of the prostate gland, spinal cord injury, injury to the bladder nerves, blockage in the urine due to kidney stones, and blood clots in the urine can cause UI. However, the BPH & prostate surgeries application segment is estimated to register the fastest CAGR during the forecast years. Based on product types, the market is divided into intermittent, foley/indwelling, and external catheters. The intermittent catheters segment dominated the overall market in 2020. This can be attributed to the increasing number of patients suffering from various urinary disorders. 

Request a free sample copy or view report summary: Urinary Catheters Market Report

Urinary Catheters Market Report Highlights

• North America was the leading regional market with the highest revenue share in 2020 and is estimated to expand further at a steady CAGR from 2021 to 2028
• This growth can be attributed to the high incidence of targeted diseases, such as UI, bladder obstruction, urinary retention, Benign Prostate Hyperplasia (BPH), and bladder cancer, in the region
• The key players are introducing technologically advanced products to gain a competitive advantage in the industry
• For instance, Coloplast is planning to expand its SpeediCath product portfolio by launching the SpeediCath Navi, which is designed especially for the treatment of patients suffering from chronic urine retention

Access Press Release@ https://www.grandviewresearch.com/press-release/global-urinary-catheters-market

Urinary Catheters Market Segmentation

Grand View Research has segmented the global urinary catheters market on the basis of product, application, and region:

Urinary Catheters Product Outlook (Revenue, USD Million, 2016 - 2028)

• Intermittent
• Foley/Indwelling
• External

Urinary Catheters Application Outlook (Revenue, USD Million, 2016 - 2028)

• Benign Prostate Hyperplasia (BPH) & Prostate Surgeries
• Urinary Incontinence
• Spinal Cord Injury
• Others

Urinary Catheters Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China (Mainland)
  • India
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Urinary Catheters Market

• Hollister, Inc.
• Medtronic PLC
• Boston Scientific Corp.
• Becton Dickinson And Company (C.R. Bard, Inc.)
• Cook Medical
• Teleflex, Inc.
• Medline Industries, Inc.
• J and M Urinary Catheters LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Flow Cytometry Market Size Projected to Rise Lucratively by 2027: Grand View Research Inc.

 

Flow Cytometry Market Growth & Trends

The global flow cytometry market size is expected to reach a value of USD 11.5 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.9% from 2021 to 2027. The high prevalence of chronic diseases, the introduction of technologically advanced flow cytometry solutions, and increasing R&D investments in the pharmaceutical industry are expected to propel market growth over the forecast period.

Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. Also, in January 2019, Beckman Coulter, a subsidiary of Danaher Corporation, expanded its clinical flow cytometry portfolio with the launch of its new ClearLLab 10C System. This newly launched integrated solution provides a standardized workflow that offers reliability and consistent clinical findings.

Technological advancements, resulting in enhanced accuracy, portability, and cost-effectiveness, are expected to present this market with future growth opportunities. Small-sized high-throughput cytometers are anticipated to gain popularity in the near future due to their associated benefits, such as ease of use and cost-effectiveness. Furthermore, improvements in fluorescent dyes and the introduction of bench-top cytometers are factors expected to drive market growth. Rapid advancements in multicolor flow cytometry, which has extensive applications in new drug development, have led to an easy cellular analysis by simultaneous evaluation of several parameters. These devices are extensively adopted by many contract research organizations.

Furthermore, the increasing prevalence of cancer, immunodeficiency disorders, and infectious diseases, including the outbreak of COVID-19, has significantly driven the demand for flow cytometry solutions for research and clinical applications. As per the American Cancer Society estimates, in 2020, around 1.8 million new cancer cases will be diagnosed in the U.S. Also, according to the data published by the National Cancer Institute (NCI), as of January 2019, there were around 16.9 million cancer survivors in the U.S.

Request a free sample copy or view report summary: Flow Cytometry Market Report

Flow Cytometry Market Report Highlights

• Instruments accounted for the largest market share in 2020, owing to its high demand for commercial and clinical applications
• The software segment is expected to register the fastest growth owing to new product developments in this field
• The research segment is anticipated to witness lucrative CAGR over the forecast period owing to increasing R&D activities pertaining to cancer and infectious diseases
• The outbreak of COVID-19 has drastically upsurged the demand for advanced flow cytometry solutions for research purposes
• North America dominated the market and accounted for the largest revenue share in 2020. Well-established healthcare infrastructure and the presence of an established pharmaceutical industry are facilitating the dominance of this region during the study period
• The Asia Pacific region is expected to witness significant growth owing to the increasing demand for flow cytometry solutions in emerging economies such as China and India

Access Press Release@ https://www.grandviewresearch.com/press-release/global-flow-cytometry-market

Flow Cytometry Market Segmentation

Grand View Research has segmented the global flow cytometry market on the basis of product, technology, application, end-use, and region:

Flow Cytometry Product Outlook (Revenue, USD Million, 2016 - 2027)

• Instruments
  • Cell Analyzers
  • Cell Sorters
• Reagents & Consumables
• Software
• Accessories
• Services

Flow Cytometry Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Cell-based
• Bead-based

Flow Cytometry Application Outlook (Revenue, USD Million, 2016 - 2027)

• Research
  • Pharmaceutical
    • Drug Discovery
    • Stem Cell
    • In Vitro Toxicity
  • Apoptosis
  • Cell Sorting
  • Cell Cycle Analysis
  • Immunology
  • Cell Viability
• Industrial
• Clinical
  • Cancer
  • Organ Transplantation
  • Immunodeficiency
  • Hematology

Flow Cytometry End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Commercial Organizations
• Hospitals
• Academic Institutes
• Clinical Testing Labs

Flow Cytometry Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Flow Cytometry Market

• Danaher Corporation
• Becton, Dickinson and Company
• Luminex Corporation
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Miltenyi Biotec
• Sysmex Corporation
• Stratedigm, Inc.
• Apogee Flow Systems Ltd.
• Sony Biotechnology, Inc.
• Thermo Fisher Scientific, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Histology & Cytology Market to Rear Excessive Growth CAGR of 13.1% from 2021 to 2028: Grand View Research Inc.

 

Histology And Cytology Market Growth & Trends

The global histology and cytology market size is expected to reach USD 37.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.1% from 2021 to 2028. The factors contributing to market growth include increasing incidence of cancer, development of advanced tools for early disease diagnosis, implementation of immunohistochemistry, and innovation in microscopy.

In addition, organizations are collaborating for the standardization of cytopathology across the world, which is driving the market. For instance, in May 2020, International Agency for Research on Cancer (IARC) entered in collaboration with The International Academy of Cytology (IAC) for publishing a series of cytopathology reporting systems, for presenting an international approach that can be used for cytopathology of different body sites. The two organizations are engaged in the expansion and development of internationally recognized diagnostic reports for cancer and other precancerous disorders worldwide.

Moreover, companies are launching new and automated instruments for cytology which can be further attributed to the market growth. For instance, ELITechGroup Inc., in March 2020, launched Aerospray Cytology Slide Stainer Cytocentrifuge. It helps in the automation of the staining and preparation of specimens that are used in liquid-based cytology for facilitating the investigation of a collection of cell differentiation by using Papanicolaou staining techniques.

COVID-19 has become a catalyst for changing traditional pathology workflows with the integration of Artificial Intelligence (AI) and digitalization solutions. During the pandemic, these tools have helped and continue to assist in remote reviewing of pathological cases hence preventing delay in patient care. Companies have reported the increasing adoption of digital pathology solutions post COVID-19.

Request a free sample copy or view report summary: Histology And Cytology Market Report

Histology And Cytology Market Report Highlights

• The cytology segment accounted for the largest revenue share in 2020 and is expected to continue the trend in the forecast period owing to the integration of computational analytical tools for advancing cytology system
• The histology is expected to witness gradual growth from 2021 to 2028 owing to moderate innovation in histological systems
• The consumables and reagents segment dominated the market, attributed to the expanding portfolios of the entities operating in the consumable market space
• The instruments and analysis software system segment is expected to witness a substantial CAGR from 2021 to 2028, attributed to the steep increase in the demand for automated histology instruments
• The cervical cancer segment represented the majority of the market in 2020 owing to the increasing application of the Pap test in the early diagnosis of cervical cancer
• Institutes are integrating computer algorithm for improving the accuracy and efficiency of cervical cancer screening
• For instance, in June 2020, an NIH study integrated a computer algorithm with cytology (Pap test) for increasing the efficiency of cervical cancer screening. The new approach involves an AI platform for dual-stain evaluation
• The other cancers segment is expected to witness a lucrative growth rate of 18.0% owing to increasing diagnosis of various cancers such as pancreatic cancer and bladder cancer with histopathology and cytopathology
• The drug discovery and designing segment accounted for the highest revenue share in 2020 owing to the growing importance of cytopathology in disease understanding, further aimed at rapid drug development
• North America accounted for the highest revenue share in 2020, owing to the prevalence of cancer, presence of key players, and developed healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-histology-cytology-market

Histology And Cytology Market Segmentation

Grand View Research has segmented the global histology and cytology market on the basis of type of examination, product, application, and region:

Histology & Cytology Type Of Examination Outlook (Revenue, USD Million, 2017 - 2028) 

• Histology
  • By Technique
    • Microscopy
    • Immunohistochemistry
    • Molecular pathology
    • Cryostat & Microtomy
  • Cytology
    • By Technique
      • Microscopy
      • Immunohistochemistry
      • Molecular pathology
      • Cryostat & Microtomy
    • By Application
      • Breast Cancer
      • Cervical Cancer
      • Bladder Cancer
      • Lung Cancer
      • Other Cancers

Histology & Cytology Product Outlook (Revenue, USD Million, 2017 - 2028)

• Instruments and Analysis Software System
• Consumable and Reagents

Histology & Cytology Application Outlook (Revenue, USD Million, 2017 - 2028)

• Drug Discovery & Designing
• Clinical Diagnostics
• Research

Histology & Cytology Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Histology And Cytology Market

• Hologic, Inc.
• Hoffmann-La Roche Ltd.
• Abbott
• Becton, Dickinson and Company
• Danaher
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation
• Trivitron Healthcare
• Koninklijke Philips N.V.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Active Pharmaceutical Ingredient Market is Expected to Enhance $312.56 Billion Revenue By 2028: Grand View Research Inc.

 

Active Pharmaceutical Ingredient Market Growth & Trends

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like “Make in India”.

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Request a free sample copy or view report summary: Active Pharmaceutical Ingredient Market Report

Active Pharmaceutical Ingredient Market Report Highlights

• According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe
• The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above
• According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke
• Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country
• Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-active-pharmaceutical-ingredients-api-market

Active Pharmaceutical Ingredient Market Segmentation

Grand View Research has segmented the global active pharmaceutical ingredients market based on type of synthesis, type of manufacturer, type, application, and region:

Active Pharmaceutical Ingredient Type of Synthesis Outlook (Revenue, USD Billion, 2017 - 2028)

• Biotech
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
• Synthetic

Active Pharmaceutical Ingredient Type of Manufacturer Outlook (Revenue, USD Billion, 2017 - 2028)

• Captive APIs
• Merchant APIs

Active Pharmaceutical Ingredient Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Generic APIs
• Innovative APIs

Active Pharmaceutical Ingredient Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Cardiovascular Diseases
• Oncology
• CNS and Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

Active Pharmaceutical Ingredient Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players of Active Pharmaceutical Ingredient Market

• Merck & Co., Inc.
• AbbVie, Inc.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• Teva Pharmaceutical Industries Ltd.
• Albemarle Corporation
• Viatris Inc.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• Reddy’s Laboratories Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.